Lasa Supergenerics Ltd - 540702 - Certificate Under Regulation 74(5) Of SEBI (Depositories And Participants) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2019 Lasa Supergenerics Ltd - 540702 - Half Yearly Certificate From Practicing Company Secretary Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosures Requirement ) Regulations 2015.
Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certificate from Amit R. Dadheech & Associates, Company Secretaries for the half year ended March 31, 2019. Lasa Supergenerics Ltd - 540702 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations,2015 For The Quarter Ended March 31, 2019
This is to certify that in compliance with regulation 7(2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, all activities in relation to share transfer facility are maintained by our Share Transfer Agent i.e. Bigshare Services Private Limited having permanent SEBI Registration No INR0000001385. This certificate for the half year ended 31 March 2019 is issued in compliance with Regulation 7(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Lasa Supergenerics Ltd - 540702 - Shareholding for the Period Ended March 31, 2019
Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- NIDHI KULSHRESHTHADesignation :- Company Secretary and Compliance Officer Lasa Supergenerics Ltd - 540702 - Closure of Trading Window
In Compliance with the requirement of the Schedule B to the SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations) and SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 we hereby inform you that the company has adopted the code of conduct Procedures for Fair Disclosure of Unpublished Price Sensitive Information by designated person pursuant to amendment in Prohibition of Insider Regulations 2018. Further, trading window of the company is closed for designated employees and their immediate relatives' w.e.f April 01st, 2019 till 72 hours after the declaration of financial result. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, please find enclosed herewith copies of un-audited Financial Result for the quarter ended December 31, 2018 which were duly approved in the Meeting of the Board of Directors held on 11th February, 2019 viz. Business Standard (English Newspaper) and Lakshya deep (Hindi Newspaper). Lasa Supergenerics Ltd - 540702 - Outcome Of Board Meeting Held Today I.E 11 February, 2019
Pursuant to Regulation 29 and Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we write to inform you that at the meeting held today at the Corporate Office of the Company which was commenced at 1.00 p.m. and concluded at 3.15 p.m. have considered, approved and took on record the Unaudited Financial Results for the quarter ended December 31, 2018. Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, please find enclosed herewith copies of newspaper advertisements. Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Intimation Of The Board Meeting And Closure Of Trading Window
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2019 ,inter alia, to consider and approve and take on record Unaudited Financial Results of the Company along with Limited Review Report for the quarter ended December 31, 2018, and/or to discuss any other business/matter with the permission of the Chairman.